Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease. In a presentation at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona (27–30 April), Associate Professor Susanna Brighenti, Center for Infectious Medicine (CIM), ANA Futura at the Karolinska Institutet, Stockholm, Sweden, presents work being done in this area by a collaboration of scientists.

from Medical Xpress - latest medical and health news stories https://ift.tt/uwxCKiH